Cheryl Xu
Fortuna: 5 259 $ al 30/09/2026
Fortuna: 5 259 $ al 30/09/2026
Cheryl Xu is currently Director at 60 Degrees Pharmaceuticals, Inc. since 2023.
Formerly, Ms. Xu was Director-International Finance at Pharmacia Corp.
and Vice President-Public Policy & Government Affairs at Biogen, Inc. Ms. Xu earned an MBA from the University of Washington and completed undergraduate studies at Peking University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/07/2026 | 3.954 ( 0,11 % ) | 5 259 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| 60 DEGREES PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 11/07/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/03/2023 |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Director Financiero/CFO | 28/03/2013 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for infectious diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.